Clinical Trial Update: Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the biodistribution and detection of radiolabeled anti-TNFα in patients with active rheumatoid arthritis and active axial/peripheral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Peripheral Spondyloarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Radiolabeled anti-TNFα

Snippet

Sponsor: University Hospital, Ghent | Conditions: Axial and Peripheral Spondyloarthritis, Rheumatoid Arthritis | Phase 3 | Status: COMPLETED